CSIMarket
 



Penumbra Inc  (PEN)
Other Ticker:  
 
 



 

What are Penumbra Inc's Business Segments?



Penumbra Inc. is a medical technology company that offers a wide range of segments, products, and services to healthcare providers globally. The company's primary focus is on developing innovative technologies that aid in the diagnosis and treatment of various medical conditions.

Segments:

1. Neuron - This segment includes an innovative product line that focuses on the treatment and diagnosis of diseases associated with blood vessels in the brain, such as cerebral aneurysms and strokes. The company's products in this segment include the Penumbra System, Coil 400, and Broughton Embolic Coil.

2. Vascular - This segment comprises of products that aid in the treatment of peripheral vascular disease, deep vein thrombosis, and pulmonary embolisms. The company's products in this segment include the Penumbra System with the Indigo Separator, Ruby Coil System, and 3D Revascularization device.

3. Cardiac - This segment includes a range of products that are designed to aid in the diagnosis and treatment of cardiac conditions, such as cardiac arrhythmias, peripheral artery disease, and heart failure. The company's products in this segment include the TRUE flow infusion system and Cobra CTO devices.

Products and Services:

1. Neuro Interventional Products - Penumbra's Neuro Interventional products are designed to offer physicians innovative technologies to treat and diagnose neurological conditions such as stroke, aneurysms, and blood vessel occlusions. These products help to prevent brain damage, improve outcomes and recovery, and reduce morbidity and mortality. Some of the company's Neuro Interventional products include the Penumbra System, Coil 400, and Broughton Embolic Coil.

2. Peripheral Vascular Products - This product line includes devices designed to treat conditions such as peripheral artery disease, deep vein thrombosis, and pulmonary embolisms. Devices such as the Penumbra System with the Indigo Separator, Ruby Coil System, and 3D Revascularization device help to reduce morbidity, improve outcomes and increase patient convenience.

3. Cardiac Intervention Products - Penumbra's Cardiac Intervention products are designed to help diagnose and treat various heart conditions, such as cardiac arrhythmias, peripheral artery disease, and heart failure. These products include TRUE flow infusion system and Cobra CTO devices, among others.

4. Clinical Training and Education - Penumbra offers training and education programs to healthcare providers to ensure that they have the knowledge and expertise necessary to use their products effectively. The company offers clinical training programs that cover basic and advanced topics in Neuro Interventional and peripheral vascular treatment, among others.

5. Technical Support - Penumbra has a team of technical support staff available 24/7 to provide support and troubleshooting for the company's products. The technical support team provides vital assistance to physicians and other healthcare providers in diagnosing and resolving issues with their Penumbra products.

In summary, Penumbra offers a comprehensive line of products and services that help diagnose and treat neurological, peripheral vascular and cardiac conditions. The company is dedicated to developing innovative technologies that help healthcare providers offer better outcomes while reducing morbidity and mortality. Its products and services are designed to improve patient experience, reduce healthcare costs, and enhance clinical outcomes.
   

Penumbra Inc Tax Rate Companies within the Medical Equipment & Supplies Industry


Business Segments Q1
Revenues
(in millions $)
Q1
Income
(in millions $)
(Mar 31 2024)
%
(Profit Margin)
Total 278.66 11.00 3.95 %

Growth rates by Segment Q1
Y/Y Revenue
%
(Mar 31 2024)
Q/Q Revenue
%
Q1
Y/Y Income
%
(Mar 31 2024)
Q/Q Income
%
Total 15.43 % -2.12 % 28.5 % -79.71 %

To get more information on Penumbra Inc's Total segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com